
Elizabeth A. Burkhart
Examiner (ID: 12400, Phone: (571)272-6647 , Office: P/1715 )
| Most Active Art Unit | 1715 |
| Art Unit(s) | 1762, 1715, 1792 |
| Total Applications | 919 |
| Issued Applications | 503 |
| Pending Applications | 11 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3692720
[patent_doc_number] => 05676927
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'Granular preparation for MRI'
[patent_app_type] => 1
[patent_app_number] => 8/424481
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6003
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/676/05676927.pdf
[firstpage_image] =>[orig_patent_app_number] => 424481
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/424481 | Granular preparation for MRI | May 11, 1995 | Issued |
Array
(
[id] => 3696576
[patent_doc_number] => 05645815
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-08
[patent_title] => 'Radiolabled compounds for thrombus imaging'
[patent_app_type] => 1
[patent_app_number] => 8/439905
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7151
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/645/05645815.pdf
[firstpage_image] =>[orig_patent_app_number] => 439905
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/439905 | Radiolabled compounds for thrombus imaging | May 11, 1995 | Issued |
Array
(
[id] => 4023057
[patent_doc_number] => 05993774
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Metal-oxime chelates for use as radiopharmaceutical agents'
[patent_app_type] => 1
[patent_app_number] => 8/411791
[patent_app_country] => US
[patent_app_date] => 1995-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6764
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/993/05993774.pdf
[firstpage_image] =>[orig_patent_app_number] => 411791
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/411791 | Metal-oxime chelates for use as radiopharmaceutical agents | May 8, 1995 | Issued |
Array
(
[id] => 3722688
[patent_doc_number] => 05702681
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Method for detecting flukicidal activity'
[patent_app_type] => 1
[patent_app_number] => 8/434610
[patent_app_country] => US
[patent_app_date] => 1995-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14341
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/702/05702681.pdf
[firstpage_image] =>[orig_patent_app_number] => 434610
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/434610 | Method for detecting flukicidal activity | May 3, 1995 | Issued |
Array
(
[id] => 3690775
[patent_doc_number] => 05660815
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => 'Water soluble fluorinated fatty acid sulfonate derivatives useful as magnetic resonance imaging agents'
[patent_app_type] => 1
[patent_app_number] => 8/431058
[patent_app_country] => US
[patent_app_date] => 1995-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6950
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/660/05660815.pdf
[firstpage_image] =>[orig_patent_app_number] => 431058
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/431058 | Water soluble fluorinated fatty acid sulfonate derivatives useful as magnetic resonance imaging agents | Apr 27, 1995 | Issued |
Array
(
[id] => 3834816
[patent_doc_number] => 05744120
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'Ternary radiopharmaceutical complexes'
[patent_app_type] => 1
[patent_app_number] => 8/415908
[patent_app_country] => US
[patent_app_date] => 1995-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14934
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744120.pdf
[firstpage_image] =>[orig_patent_app_number] => 415908
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/415908 | Ternary radiopharmaceutical complexes | Apr 2, 1995 | Issued |
Array
(
[id] => 3621388
[patent_doc_number] => 05620676
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Biologically active ATP analogs'
[patent_app_type] => 1
[patent_app_number] => 8/414438
[patent_app_country] => US
[patent_app_date] => 1995-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 24573
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/620/05620676.pdf
[firstpage_image] =>[orig_patent_app_number] => 414438
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/414438 | Biologically active ATP analogs | Mar 30, 1995 | Issued |
Array
(
[id] => 3763331
[patent_doc_number] => 05849261
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Radiolabeled vasoactive intestinal peptides for diagnosis and therapy'
[patent_app_type] => 1
[patent_app_number] => 8/414424
[patent_app_country] => US
[patent_app_date] => 1995-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17618
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849261.pdf
[firstpage_image] =>[orig_patent_app_number] => 414424
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/414424 | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy | Mar 30, 1995 | Issued |
Array
(
[id] => 3904268
[patent_doc_number] => 05897873
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-27
[patent_title] => 'Affinity associated vaccine'
[patent_app_type] => 1
[patent_app_number] => 8/392676
[patent_app_country] => US
[patent_app_date] => 1995-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5890
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/897/05897873.pdf
[firstpage_image] =>[orig_patent_app_number] => 392676
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/392676 | Affinity associated vaccine | Feb 22, 1995 | Issued |
Array
(
[id] => 4209427
[patent_doc_number] => 06086849
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Technetium-99m labeled peptides for imaging'
[patent_app_type] => 1
[patent_app_number] => 8/170299
[patent_app_country] => US
[patent_app_date] => 1995-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13081
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/086/06086849.pdf
[firstpage_image] =>[orig_patent_app_number] => 170299
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/170299 | Technetium-99m labeled peptides for imaging | Feb 8, 1995 | Issued |
Array
(
[id] => 3734002
[patent_doc_number] => 05753205
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Radiolabelled peptide compounds'
[patent_app_type] => 1
[patent_app_number] => 8/372547
[patent_app_country] => US
[patent_app_date] => 1995-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3729
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753205.pdf
[firstpage_image] =>[orig_patent_app_number] => 372547
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/372547 | Radiolabelled peptide compounds | Jan 12, 1995 | Issued |
Array
(
[id] => 3644174
[patent_doc_number] => 05639439
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-17
[patent_title] => 'Gallium dimercaptosuccinate as a novel tumor imaging agent'
[patent_app_type] => 1
[patent_app_number] => 8/356895
[patent_app_country] => US
[patent_app_date] => 1994-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 973
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/639/05639439.pdf
[firstpage_image] =>[orig_patent_app_number] => 356895
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/356895 | Gallium dimercaptosuccinate as a novel tumor imaging agent | Dec 14, 1994 | Issued |
Array
(
[id] => 3721239
[patent_doc_number] => 05700445
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-23
[patent_title] => 'N-methyl piperazine compounds having dopamine receptor affinity'
[patent_app_type] => 1
[patent_app_number] => 8/354905
[patent_app_country] => US
[patent_app_date] => 1994-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5777
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/700/05700445.pdf
[firstpage_image] =>[orig_patent_app_number] => 354905
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/354905 | N-methyl piperazine compounds having dopamine receptor affinity | Dec 11, 1994 | Issued |
Array
(
[id] => 3881379
[patent_doc_number] => 05723103
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Substituted benzamides and radioligand analogs and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/352277
[patent_app_country] => US
[patent_app_date] => 1994-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 6
[patent_no_of_words] => 11303
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723103.pdf
[firstpage_image] =>[orig_patent_app_number] => 352277
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/352277 | Substituted benzamides and radioligand analogs and methods of use | Dec 8, 1994 | Issued |
Array
(
[id] => 3736471
[patent_doc_number] => 05698583
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Oligoelements and phospholipase A2 immuno-enhancer compositions, preparation thereof, and use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/339747
[patent_app_country] => US
[patent_app_date] => 1994-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10622
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698583.pdf
[firstpage_image] =>[orig_patent_app_number] => 339747
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/339747 | Oligoelements and phospholipase A2 immuno-enhancer compositions, preparation thereof, and use thereof | Nov 14, 1994 | Issued |
Array
(
[id] => 3882853
[patent_doc_number] => 05833944
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'Procedure for the solid phase synthesis of .sup.35 S-labeled oligonucleotides with 3H-1,2-benzodithiol-3-one-1,1-dioxide'
[patent_app_type] => 1
[patent_app_number] => 8/335100
[patent_app_country] => US
[patent_app_date] => 1994-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 4048
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/833/05833944.pdf
[firstpage_image] =>[orig_patent_app_number] => 335100
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/335100 | Procedure for the solid phase synthesis of .sup.35 S-labeled oligonucleotides with 3H-1,2-benzodithiol-3-one-1,1-dioxide | Nov 6, 1994 | Issued |
Array
(
[id] => 4057200
[patent_doc_number] => 05866097
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Technetium-99m labeled peptides for imaging'
[patent_app_type] => 1
[patent_app_number] => 8/244336
[patent_app_country] => US
[patent_app_date] => 1994-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3370
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 373
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866097.pdf
[firstpage_image] =>[orig_patent_app_number] => 244336
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/244336 | Technetium-99m labeled peptides for imaging | Oct 27, 1994 | Issued |
Array
(
[id] => 3820281
[patent_doc_number] => 05730954
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Preparation comprising cavitate- or clathrate-forming host/guest complexes as contrast agent'
[patent_app_type] => 1
[patent_app_number] => 8/322966
[patent_app_country] => US
[patent_app_date] => 1994-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4019
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/730/05730954.pdf
[firstpage_image] =>[orig_patent_app_number] => 322966
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/322966 | Preparation comprising cavitate- or clathrate-forming host/guest complexes as contrast agent | Oct 12, 1994 | Issued |
Array
(
[id] => 3535056
[patent_doc_number] => 05556939
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-17
[patent_title] => 'TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications'
[patent_app_type] => 1
[patent_app_number] => 8/322880
[patent_app_country] => US
[patent_app_date] => 1994-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9576
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/556/05556939.pdf
[firstpage_image] =>[orig_patent_app_number] => 322880
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/322880 | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications | Oct 12, 1994 | Issued |
Array
(
[id] => 3678400
[patent_doc_number] => 05632969
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-27
[patent_title] => 'N.sub.3 S.sub.2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications'
[patent_app_type] => 1
[patent_app_number] => 8/322881
[patent_app_country] => US
[patent_app_date] => 1994-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9458
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/632/05632969.pdf
[firstpage_image] =>[orig_patent_app_number] => 322881
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/322881 | N.sub.3 S.sub.2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications | Oct 12, 1994 | Issued |